Deal With AstraZeneca May Be Deemed Void If Vaccine Fails To Get FDA Approval, Says DOH

AstraZeneca

The recently-signed deal may be deemed void if AstraZeneca COVID-19 vaccine failed to secure an FDA approval, according to DOH. The Department of Health (DOH) on Monday said that the recently-signed deal between AstraZeneca, the private sector, and the Philippine government may be deemed void if AstraZeneca COVID-19 vaccine failed to secure an approval from … Read more

More Companies Want To Join AstraZeneca Supply Deal, Says Gov’t Adviser

AstraZeneca

More companies wanted to join AstraZeneca supply deal, according to one of the Philippines’ presidential advisers. One of the Philippines’ presidential advisers on Monday said that more companies wanted to join the agreement between private sector and the Philippine government in securing a supply of AstraZeneca COVID-19 vaccine. This, after senior officials announced that the … Read more

AstraZeneca COVID-19 Vaccine To Go Through Stringent Clinical Trial In PH, Says Galvez

AstraZeneca

AstraZeneca COVID-19 Vaccine would undergo stringent clinical trial in the Philippines, according to Galvez. COVID-19 Vaccine Czar Secretary Carlito Galvez Jr. on Saturday said that AstraZeneca would undergo stringent clinical trial for its COVID-19 vaccine in the Philippines. This, as he allayed fears on potential local use of AstraZeneca COVID-19 vaccine amidst questions on its … Read more

AstraZeneca: COVID-19 Vaccine Needs “Additional Study”

AstraZeneca

An “additional study” on its COVID-19 vaccine was needed, according to the head of AstraZeneca. The head of British vaccine manufacturer AstraZeneca on Thursday said that an “additional study” on its COVID-19 vaccine was needed after questions popped up over the protection it offered. However, in a report on Agence France-Presse, the additional testing was … Read more

COVID-19 Vaccine Can Be ‘90% Effective’, Says AstraZeneca

AstraZeneca

COVID-19 vaccine can be “90% effective”, according to AstraZeneca. AstraZeneca on Monday said that its COVID-19 vaccine was 70 percent effective in pivotal trials and could be up to 90 percent effective. This, as it gave the world’s fight against COVID-19 pandemic a third new weapon that can be easier to distribute, cheaper to make, … Read more